1. Home
  2. DVA vs DUOL Comparison

DVA vs DUOL Comparison

Compare DVA & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • DUOL
  • Stock Information
  • Founded
  • DVA 1994
  • DUOL 2011
  • Country
  • DVA United States
  • DUOL United States
  • Employees
  • DVA N/A
  • DUOL N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • DVA Health Care
  • DUOL Technology
  • Exchange
  • DVA Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • DVA 15.2B
  • DUOL 14.9B
  • IPO Year
  • DVA 1995
  • DUOL 2021
  • Fundamental
  • Price
  • DVA $147.01
  • DUOL $295.56
  • Analyst Decision
  • DVA Hold
  • DUOL Buy
  • Analyst Count
  • DVA 5
  • DUOL 13
  • Target Price
  • DVA $154.40
  • DUOL $385.00
  • AVG Volume (30 Days)
  • DVA 1.3M
  • DUOL 1.2M
  • Earning Date
  • DVA 05-01-2025
  • DUOL 02-27-2025
  • Dividend Yield
  • DVA N/A
  • DUOL N/A
  • EPS Growth
  • DVA 44.61
  • DUOL 437.14
  • EPS
  • DVA 10.73
  • DUOL 1.88
  • Revenue
  • DVA $12,815,550,000.00
  • DUOL $748,024,000.00
  • Revenue This Year
  • DVA $5.76
  • DUOL $31.71
  • Revenue Next Year
  • DVA $3.59
  • DUOL $24.85
  • P/E Ratio
  • DVA $13.70
  • DUOL $157.21
  • Revenue Growth
  • DVA 5.56
  • DUOL 40.84
  • 52 Week Low
  • DVA $125.64
  • DUOL $145.05
  • 52 Week High
  • DVA $179.60
  • DUOL $441.77
  • Technical
  • Relative Strength Index (RSI)
  • DVA 41.48
  • DUOL 34.09
  • Support Level
  • DVA $138.64
  • DUOL $276.67
  • Resistance Level
  • DVA $149.06
  • DUOL $412.88
  • Average True Range (ATR)
  • DVA 4.76
  • DUOL 23.06
  • MACD
  • DVA -0.71
  • DUOL -14.84
  • Stochastic Oscillator
  • DVA 42.77
  • DUOL 15.85

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

Share on Social Networks: